EUVIMEDEUVIMED entdecken
Crossref

CXCL14 Promotes Ovarian Cancer Progression and Autophagy Through the IKBKE/NF‐κB Pathway

Yan Lingling, Rao Yanqiu, Zhu Xuchao, Liu Menbing, Liu Jiangang

The Journal of Gene Medicine · 2026

DOI: 10.1002/jgm.70084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Gene Medicine, 2026. Verfasst von Yan Lingling und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Puren Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Autophagy, Signal Transduction, I-kappa B Kinase. Die Arbeit nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer remains a leading cause of gynecological malignancy‐related deaths, necessitating the identification of novel molecular pathways driving tumor progression. Utilizing a data‐driven approach, we conducted bioinformatic analyses of TCGA and GEO datasets, identifying a significant upregulation of CXCL14 in ovarian cancer tissues, which correlates with poor patient survival. Functional assays demonstrated that overexpression of CXCL14 enhances ovarian cancer cell proliferation, invasion, and autophagy. Mechanistically, CXCL14 activates the canonical NF‐κB signaling pathway by inducing phosphorylation and degradation of IκBα, leading to phosphorylation and nuclear translocation of p65. Importantly, we identified IKBKE as a critical kinase mediating CXCL14‐induced activation of the canonical NF‐κB pathway through phosphorylation of IκBα. Knockdown of IKBKE effectively attenuates CXCL14‐driven NF‐κB activation, thereby suppressing cell proliferation, invasion, and autophagy. In vivo, CXCL14 overexpression markedly enhances ovarian tumor growth, accompanied by increased levels of IKBKE and phosphorylated p65. These findings elucidate a novel regulatory axis, CXCL14/IKBKE/NF‐κB, in ovarian cancer progression, highlighting CXCL14 as a potential therapeutic target for ovarian cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsAutophagySignal TransductionI-kappa B KinaseChemokines, CXCNF-kappa BFemaleHumansAnimalsCell ProliferationDisease ProgressionCell Line, TumorGene Expression Regulation, NeoplasticMice

Stichwörter der Autor:innen

CXCL14NF‐κBautophagyovarian cancer

Substanzen

CXCL14 protein, humanI-kappa B KinaseChemokines, CXCNF-kappa B

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Puren Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China.
  • Department of Integrated Traditional and Western Medicine, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.

Zitieren

APA

Lingling, Y., Yanqiu, R., Xuchao, Z., Menbing, L., & Jiangang, L. (2026). CXCL14 Promotes Ovarian Cancer Progression and Autophagy Through the IKBKE/NF‐κB Pathway. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.70084

Vancouver

Lingling Y, Yanqiu R, Xuchao Z, Menbing L, Jiangang L. CXCL14 Promotes Ovarian Cancer Progression and Autophagy Through the IKBKE/NF‐κB Pathway. The Journal of Gene Medicine. 2026. doi:10.1002/jgm.70084

BibTeX
@article{Lingling2026,
  author = {Lingling, Yan and Yanqiu, Rao and Xuchao, Zhu and Menbing, Liu and Jiangang, Liu},
  title = {CXCL14 Promotes Ovarian Cancer Progression and Autophagy Through the IKBKE/NF‐κB Pathway},
  journal = {The Journal of Gene Medicine},
  year = {2026},
  doi = {10.1002/jgm.70084}
}
Kostenlos starten →